Vendor
2 FDA submission entries in this directory. This is not a count of distinct commercial offers.
Claim vendor profileEach entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.
Prepare with a buyer guide:
Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families
Neosoma, Inc.
Authorized purpose: Neosoma Brain Mets semi-automatically segments and contours previously diagnosed brain metastases on T1 post-contrast brain MRI to support radiation-oncology treatment planning.
Neosoma Inc.
Authorized purpose: Semi-automatic labeling, visualization, and volumetric quantification of high-grade brain glioma, including WHO grade 3 astrocytoma, grade 4 astrocytoma, and grade 4 glioblastoma, from standard MRI in patients aged 18 or older with pathologically proven high-grade glioma; prior measurements may be compared when available, but the device is not for primary diagnosis.